Experimental Breast Cancer Drug Floods Tumors with a “Surge” of Toxic Lipids
A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer...
Wayne State University and the Barbara Ann Karmanos Cancer Institute have launched a pioneering initiative to tackle cancer disparities exacerbated...
In a groundbreaking advancement for the treatment of large B-cell lymphoma (LBCL), researchers have demonstrated that metabolic tumor volume (MTV),...
A groundbreaking study spearheaded by Henry Daniell and his team at the University of Pennsylvania’s School of Dental Medicine has...
New research from the University of Toronto and the University Health Network shines a piercing light on the enduring shadows...
In a landmark study published on April 22, 2026, researchers have shed significant light on a contentious surgical debate pivotal...
Gamma delta (γδ) T cells represent an intriguing subset of the immune system that has garnered increasing attention for their...
In a groundbreaking advance poised to reshape the therapeutic landscape of lung cancer treatment, researchers have identified a novel small...
The National Center for Radiation Research in Oncology – OncoRay has recently embarked on a groundbreaking initiative that promises to...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by empowering the immune system to recognize and attack tumor cells. However,...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine